Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PLMA In Brief

This article was originally published in The Tan Sheet

Executive Summary

Perrigo predictor: Private label firm unveils its Easy Ovulation Predictor, equivalent to Inverness Medical Innovations' Clearblue Easy, at the Private Label Manufacturers Association trade show Nov. 16-18 in Chicago. The seven-test kit will ship in January. Perrigo also launched adult low-strength aspirin, a national brand equivalent (NBE) to McNeil Consumer & Specialty Pharmaceutical's St. Joseph's. The 81 mg coated tablets come in a 180-count bottle. Separately, the Allegan, Mich.-based firm received approval this month for a product comparable to Aleve Cold & Sinus...

You may also be interested in...



P&G Promotes Clearblue Advanced Digital To Keep Ovulation Test Lead

P&G launches a promotional campaign for the first digital test that can indicate a woman’s peak four days of ovulation under the Clearblue brand, which it markets for manufacturer SPD Swiss Precision Diagnostics.

P&G Promotes Clearblue Advanced Digital To Keep Ovulation Test Lead

P&G launches a promotional campaign for the first digital test that can indicate a woman’s peak four days of ovulation under the Clearblue brand, which it markets for manufacturer SPD Swiss Precision Diagnostics.

ScripsAmerica Launches RapiMed To Beat Tylenol Meltaways

ScripsAmerica Inc.’s new RapiMed line of orally dissolving pediatric painkillers seeks to beat McNeil Consumer Healthcare’s Tylenol Meltaways’ return to the market and steal share from private label by promising to melt faster, taste better and cost less. The products also address FDA dosing concerns and target Hispanic shoppers.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS096196

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel